This article has been updated from a previous version to include additional comments from Cliff Reid regarding the expected cost of Complete's services.

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) - Complete Genomics is on the cusp of launching its commercial operations and is aiming to sequence several thousand human genomes this year — and potentially up to a million human genomes over the next five years — company officials told investors Wednesday at the JP Morgan Healthcare Conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.